LNSR vs. MODD, CODX, CTCX, ICU, RVP, AKLI, FEMY, GBS, NMTC, and MDAI
Should you be buying LENSAR stock or one of its competitors? The main competitors of LENSAR include Modular Medical (MODD), Co-Diagnostics (CODX), Carmell (CTCX), SeaStar Medical (ICU), Retractable Technologies (RVP), Akili (AKLI), Femasys (FEMY), GBS (GBS), NeuroOne Medical Technologies (NMTC), and Spectral AI (MDAI). These companies are all part of the "surgical & medical instruments" industry.
Modular Medical (NASDAQ:MODD) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, community ranking, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.
In the previous week, Modular Medical had 2 more articles in the media than LENSAR. MarketBeat recorded 3 mentions for Modular Medical and 1 mentions for LENSAR. LENSAR's average media sentiment score of 0.00 equaled Modular Medical'saverage media sentiment score.
Modular Medical has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.
Modular Medical has a net margin of 0.00% compared to Modular Medical's net margin of -34.11%. Modular Medical's return on equity of -40.53% beat LENSAR's return on equity.
Modular Medical has a beta of 0.5, indicating that its share price is 50% less volatile than the S&P 500. Comparatively, LENSAR has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500.
27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 40.2% of LENSAR shares are owned by institutional investors. 32.3% of Modular Medical shares are owned by company insiders. Comparatively, 66.0% of LENSAR shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
LENSAR received 3 more outperform votes than Modular Medical when rated by MarketBeat users. However, 100.00% of users gave Modular Medical an outperform vote while only 38.46% of users gave LENSAR an outperform vote.
Modular Medical currently has a consensus price target of $4.25, suggesting a potential upside of 148.54%. LENSAR has a consensus price target of $8.00, suggesting a potential upside of 135.99%. Given LENSAR's higher possible upside, research analysts plainly believe Modular Medical is more favorable than LENSAR.
Summary
Modular Medical beats LENSAR on 9 of the 15 factors compared between the two stocks.
Get LENSAR News Delivered to You Automatically
Sign up to receive the latest news and ratings for LNSR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LNSR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
